SMTL ID : 5zv2.1 (1 other biounit)

FGFR-1 in complex with ligand lenvatinib

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.86 Å

Oligo State

monomer

Ligands

1 x LEV: 4-{3-chloro-4-[(cyclopropylcarbamoyl)amino]phenoxy}-7-methoxyquinoline-6-carboxamide(Non-covalent)

LEV.1: 18 residues within 4Å: Chain A: L.25, G.26, F.30, V.33, A.53, K.55, E.72, M.76, V.102, E.103, Y.104, A.105, S.106, G.108, L.171, A.181, D.182, F.183 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:F.30, A:F.30, A:F.30, A:V.33, A:A.53, A:E.72, A:A.181 Hydrogen bonds: A:E.72, A:E.72, A:E.72, A:A.105, A:G.108, A:D.182, A:D.182

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Matsuki, M. et al., Lenvatinib inhibits angiogenesis and tumor fibroblast growth factor signaling pathways in human hepatocellular carcinoma models. Cancer Med (2018)

Release Date

2018-07-11

Peptides

Fibroblast growth factor receptor 1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Fibroblast growth factor receptor 1

Related Entries With Identical Sequence